Biofrontera
Price & Volume
Stats
See more52W Range | $0.53-$1.54 |
Market Cap | $9.7M |
Shares Short | 185,382 |
Financials
See moreRevenue (12 Mos) | $39.1M |
Revenue Growth (YoY) | 15.2% |
Gross Profit (12 Mos) | $23.1M |
Diluted EPS | -$0.81 |
News
See moreYahoo Finance • 3 days ago
Biofrontera signals enhanced operating leverage as U.S. independence and new patent reshape outlook
Yahoo Finance • 3 days ago
Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update
Yahoo Finance • 6 days ago
Biofrontera Inc. Appoints George Jones as Chief Commercial Officer
Yahoo Finance • 13 days ago
Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025
About
CEO | Dr. Hermann Luebbert Ph.D. |
Address | 120 Presidential Way, Woburn, MA, United States, 01801 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 92 |
